CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients With Advanced Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT05788484
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:41.590906+00:00
Published At: 2025-06-15T00:00:00+00:00
Record Updated At: 2025-06-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-small Cell Lung Cancer", "Gastric Cancer", "Head and Neck Cancer", "Ovarian Cancer", "Primary Peritoneal Carcinoma", "Fallopian Tube Cancer", "Bladder Urothelial Carcinoma", "Colorectal Cancer", "Esophageal Cancer", "Hepatic Cancer", "Renal Cell Carcinoma", "Cholangiocarcinoma", "Pancreatic Cancer", "Other Solid Tumors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-06-15"
protocolSection.identificationModule.nctId: "NCT05788484"
protocolSection.identificationModule.officialTitle: "A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients With Advanced Malignancies"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.